Clinical Trial Update: Surgical Nivolumab And Ipilimumab For Recurrent GBM [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update describes the surgical administration of nivolumab and ipilimumab for recurrent glioblastoma, with the study currently active bu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• OPDIVO (nivolumab)
• Yervoy (ipilimumab)

Snippet

Sponsor: Patrick Wen, MD | Conditions: Glioblastoma, GBM | Phase 1 | Status: ACTIVE_NOT_RECRUITING